Bolt Biotherapeutics (BOLT) EBIT Margin (2020 - 2026)
Bolt Biotherapeutics (BOLT) reported EBIT Margin of -167480.00% for Q2 2026, down 166969.47 percentage points from -510.53% a year earlier and down 138245.38 percentage points from the prior quarter.
Bolt Biotherapeutics (BOLT) EBIT Margin (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Bolt Biotherapeutics' EBIT Margin came in at -654.53%, up 657.78 percentage points year-over-year; for FY2025, it came in at -469.30%, up 480.60 percentage points from FY2024.
- EBIT Margin has increased for five consecutive years, with a five-year change of +20821.60 percentage points (FY2020 to FY2025).
- By year, EBIT Margin came in at -949.91% in FY2024 (+17.54 pp), -967.45% in FY2023 (+609.11 pp), -1576.56% in FY2022 (+5787.57 pp) and -7364.13% in FY2021 (+13926.78 pp).
- The Q2 2026 figure ranks as the lowest quarterly EBIT Margin in data going back to Q1 2020.
- Year over year, EBIT Margin gained in two of the last six quarters, with an average year-over-year change of -32375.68 percentage points.
- The high point for year-over-year EBIT Margin in five years was Q4 2022 (a gain of 3838.58 percentage points); the low point was Q2 2026 (a drop of 166969.47 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -29234.62% (Q1 2026), -283.40% (Q4 2025) and -355.14% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Bolt Biotherapeutics | 6.88 Mn | 6.88 Mn | - | -167,480.00% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -167,480.00% |
| Mar 31, 2026 | -29,234.62% |
| Dec 31, 2025 | -283.40% |
| Sep 30, 2025 | -355.14% |
| Jun 30, 2025 | -510.53% |
| Mar 31, 2025 | -991.41% |
| Sep 30, 2024 | -1,441.10% |
| Jun 30, 2024 | -1,772.31% |
| Mar 31, 2024 | -324.08% |
| Dec 31, 2023 | -946.19% |
| Sep 30, 2023 | -719.26% |
| Jun 30, 2023 | -1,383.95% |
| Mar 31, 2023 | -1,008.49% |
| Dec 31, 2022 | -1,491.14% |
| Sep 30, 2022 | -1,058.05% |
| Jun 30, 2022 | -1,655.35% |
| Mar 31, 2022 | -2,936.78% |
| Dec 31, 2021 | -5,329.72% |
| Sep 30, 2021 | -3,128.46% |
| Jun 30, 2020 | -16,582.09% |
Bolt Biotherapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=BOLT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "BOLT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=BOLT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();